Bruce Pritchard

Bruce Philip Pritchard is Chief Executive Officer at Liminal BioSciences, Inc. since 2020, and has been with the company since 2008.
Holds positions as Non-Executive Director at Being Digital Ltd., Porton Biopharma Ltd., and Scottish Global Health Foundation (since 2013).
Serves as Director at Fairhaven Pharmaceuticals, Inc. Former roles include Chief Executive Officer & Director at Grifols Canada Plasma Resources, Inc., Senior Director at CV Therapeutics, Inc. from 2004 to 2006, Finance Director at Ardana Plc from 2003 to 2004, Director at Astrea Bioseparations Ltd. and Liminal BioSciences Ltd., Non-Executive Director at Imanova Ltd. from 2012 to 2017, Member at The Institute of Chartered Accountants of Scotland from 2009 to 2015, Chief Financial Officer at ProMetic BioSciences Ltd., and Member-Examiners Board at The Institute of Directors (United Kingdom) from 2011 to 2016.
Completed undergraduate degree at Heriot-Watt University in 1993.